ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO0994

Atypical Recurrence of Adenine Phosphoribosyltransferase Deficiency-Associated Nephropathy After Kidney Transplant: A Case Report

Session Information

Category: Transplantation

  • 2102 Transplantation: Clinical

Authors

  • ElSharkawy, Magdy, Ain Shams University Faculty of Medicine, Cairo, Cairo Governorate, Egypt
  • Ahmed, Fatma Abdelrahman, Ain Shams University Faculty of Medicine, Cairo, Cairo Governorate, Egypt
  • Abd El-Mohsen, Mohamed Atef, Ain Shams University Faculty of Medicine, Cairo, Cairo Governorate, Egypt
  • Abd El Azim, Mahmoud Nady Abd El Aziz, Ain Shams University Faculty of Medicine, Cairo, Cairo Governorate, Egypt
  • Teama, Nahla Mohamed, Ain Shams University Faculty of Medicine, Cairo, Cairo Governorate, Egypt
  • Abdallah, Shaimaa Zaki abdelmegied, Ain Shams University Faculty of Medicine, Cairo, Cairo Governorate, Egypt
  • Adel, Wedad, Ain Shams University Faculty of Medicine, Cairo, Cairo Governorate, Egypt
  • Elbraky, Abdelrahman Ali, Ain Shams University Faculty of Medicine, Cairo, Cairo Governorate, Egypt
  • Elsharabasy, Reem Mohsen, Ain Shams University Faculty of Medicine, Cairo, Cairo Governorate, Egypt
  • Fathy, Salma, Ain Shams University Faculty of Medicine, Cairo, Cairo Governorate, Egypt
  • Shehata, Rana Ibrahim, Ain Shams University Faculty of Medicine, Cairo, Cairo Governorate, Egypt
  • Abdelrehim, Mohamed Ahmed, Ain Shams University Faculty of Medicine, Cairo, Cairo Governorate, Egypt
  • Rady, Aliaa Osama, Ain Shams University Faculty of Medicine, Cairo, Cairo Governorate, Egypt
  • Emara, Ahmed, Ain Shams University Faculty of Medicine, Cairo, Cairo Governorate, Egypt
Introduction

Adenine phosphoribosyltransferase (APRT) deficiency is a rare autosomal recessive disorder of purine metabolism leading to accumulation of 2,8-dihydroxyadenine (DHA) crystals. These crystals can cause nephrolithiasis, tubulointerstitial nephropathy, and progressive kidney failure. This case describes an atypical recurrence of DHA crystal nephropathy alongside acute cellular rejection.

Case Description

A 24-year-old male with ESRD of 8 months duration with no history of nephrolithiasis, underwent kidney transplantation in 2024. Family history revealed consanguinity, with history of renal stones in paternal grandfather and maternal uncle. Pre-transplant workup showed HLA mismatch 2-0-1, negative crossmatches, mild proteinuria, and urate crystals in urine, but no nephrolithiasis or nephrocalcinosis on imaging. He received a living-donor kidney from his parentral aunt and was started on Anti-Thymocyte Globulin (ATG), tacrolimus, mycophenolate mofetil and prednisone.
Initial graft function was good (creatinine 0.9 mg/dL by post operative day (POD) 3), but worsened by POD 15 (creatinine 1.5 mg/dL). Urinalysis showed persistent urate-like crystals, with normal serum uric acid. Renal biopsy revealed acute T-cell–mediated rejection (Banff IIB). C4d was negative, but DHA crystals were identified, confirming recurrent APRT-related nephropathy. He was initially treated with pulse steroids and additional 3 doses of ATG for presumed rejection. After APRT deficiency was confirmed, febuxostat (80 mg/day) was started. Renal function improved (creatinine 1.3 mg/dL), with gradual crystalluria resolution.

Discussion

APRT deficiency is a rare but significant cause of recurrent nephropathy, often misdiagnosed as uric acid nephropathy due to radiolucent DHA crystals, leading to delayed treatment and early graft dysfunction. Early diagnosis and initiation of xanthine oxidase inhibitors are crucial for preserving graft function. This case raises awareness about APRT deficiency-associated nephropathy as a potential cause of early graft dysfunction post-transplant. Misdiagnosis as rejection can lead to inappropriate treatment.

Digital Object Identifier (DOI)